SNORD88B and liver cancer: Recent studies have shown that SNORD88B is highly expressed in liver cancer stem cells (CSCs) and liver cancer samples, where it promotes the binding of XRCC5 to the STK4 promoter, thereby inhibiting STK4 transcription.